Article
Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
Pathology, research and practice - 1 Jul 2021
Sun Qingrong, Chen Siyi, Hou Yingjian, Wen Xiaodong, Teng Xiaodong, Zhang Honghe, Lai Chong, Lai Maode
Abstract excerpt
OBJECTIVE: Metastatic renal cell carcinoma (mRCC) is the important factor for patient mortality, meanwhile gene mutation constantly changes cancer prognosis in tumor process. Exploring the driver mutation in mRCC process become more and more important. MATERIALS AND METHODS: We obtained the 15 paired primary and metastatic mRCC samples and analyzed specific mutation genes in the metastatic foci (SMGs) by next...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
